These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25339768)

  • 1. Uneven genetic robustness of HIV-1 integrase.
    Rihn SJ; Hughes J; Wilson SJ; Bieniasz PD
    J Virol; 2015 Jan; 89(1):552-67. PubMed ID: 25339768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extreme genetic fragility of the HIV-1 capsid.
    Rihn SJ; Wilson SJ; Loman NJ; Alim M; Bakker SE; Bhella D; Gifford RJ; Rixon FJ; Bieniasz PD
    PLoS Pathog; 2013; 9(6):e1003461. PubMed ID: 23818857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of capsid mutations that alter the rate of HIV-1 uncoating in infected cells.
    Hulme AE; Kelley Z; Okocha EA; Hope TJ
    J Virol; 2015 Jan; 89(1):643-51. PubMed ID: 25339776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compensatory substitutions in the HIV-1 capsid reduce the fitness cost associated with resistance to a capsid-targeting small-molecule inhibitor.
    Shi J; Zhou J; Halambage UD; Shah VB; Burse MJ; Wu H; Blair WS; Butler SL; Aiken C
    J Virol; 2015 Jan; 89(1):208-19. PubMed ID: 25320302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of the C-terminal region within the catalytic core domain of HIV-1 integrase to yeast lethality, chromatin binding and viral replication.
    Xu Z; Zheng Y; Ao Z; Clement M; Mouland AJ; Kalpana GV; Belhumeur P; Cohen EA; Yao X
    Retrovirology; 2008 Nov; 5():102. PubMed ID: 19014595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of HIV-1 integrase resistance mutations when introduced into SIVmac239 on susceptibility to integrase strand transfer inhibitors.
    Hassounah SA; Mesplède T; Quashie PK; Oliveira M; Sandstrom PA; Wainberg MA
    J Virol; 2014 Sep; 88(17):9683-92. PubMed ID: 24920794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of the G118R, H51Y, and E138K resistance substitutions in different subtypes of HIV integrase.
    Quashie PK; Oliviera M; Veres T; Osman N; Han YS; Hassounah S; Lie Y; Huang W; Mesplède T; Wainberg MA
    J Virol; 2015 Mar; 89(6):3163-75. PubMed ID: 25552724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and virological analysis of the 18-residue C-terminal tail of HIV-1 integrase.
    Dar MJ; Monel B; Krishnan L; Shun MC; Di Nunzio F; Helland DE; Engelman A
    Retrovirology; 2009 Oct; 6():94. PubMed ID: 19840380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic barrier to the development of resistance to integrase inhibitors in HIV-1 subtypes CRF01_AE and B.
    Nguyen HL; Ruxrungtham K; Delaugerre C
    Intervirology; 2012; 55(4):287-95. PubMed ID: 22456540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of recombinant integrase activity and functional preintegration complex formation during acute infection by replication-defective integrase mutant human immunodeficiency virus.
    Li X; Koh Y; Engelman A
    J Virol; 2012 Apr; 86(7):3861-79. PubMed ID: 22278243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-site suppressors of HIV-1 capsid mutations: restoration of intracellular activities without correction of intrinsic capsid stability defects.
    Yang R; Shi J; Byeon IJ; Ahn J; Sheehan JH; Meiler J; Gronenborn AM; Aiken C
    Retrovirology; 2012 Apr; 9():30. PubMed ID: 22515365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered viral fitness and drug susceptibility in HIV-1 carrying mutations that confer resistance to nonnucleoside reverse transcriptase and integrase strand transfer inhibitors.
    Hu Z; Kuritzkes DR
    J Virol; 2014 Aug; 88(16):9268-76. PubMed ID: 24899199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of human immunodeficiency virus type 1 integrase in uncoating of the viral core.
    Briones MS; Dobard CW; Chow SA
    J Virol; 2010 May; 84(10):5181-90. PubMed ID: 20219923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphic substitution E157Q in HIV-1 integrase increases R263K-mediated dolutegravir resistance and decreases DNA binding activity.
    Anstett K; Cutillas V; Fusco R; Mesplède T; Wainberg MA
    J Antimicrob Chemother; 2016 Aug; 71(8):2083-8. PubMed ID: 27084918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INI1/hSNF5-interaction defective HIV-1 IN mutants exhibit impaired particle morphology, reverse transcription and integration in vivo.
    Mathew S; Nguyen M; Wu X; Pal A; Shah VB; Prasad VR; Aiken C; Kalpana GV
    Retrovirology; 2013 Jun; 10():66. PubMed ID: 23799881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The R263K substitution in HIV-1 subtype C is more deleterious for integrase enzymatic function and viral replication than in subtype B.
    Mesplède T; Quashie PK; Hassounah S; Osman N; Han Y; Liang J; Singhroy DN; Wainberg MA
    AIDS; 2015 Jul; 29(12):1459-66. PubMed ID: 26244385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro functional analyses of the human immunodeficiency virus type 1 (HIV-1) integrase mutants give new insights into the intasome assembly.
    Cellier C; Moreau K; Gallay K; Ballandras A; Gouet P; Ronfort C
    Virology; 2013 May; 439(2):97-104. PubMed ID: 23473371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect on HIV-1 viral replication capacity of DTG-resistance mutations in NRTI/NNRTI resistant viruses.
    Pham HT; Mesplède T; Wainberg MA
    Retrovirology; 2016 Apr; 13(1):31. PubMed ID: 27130466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration.
    Mesplède T; Leng J; Pham HT; Liang J; Quan Y; Han Y; Wainberg MA
    mBio; 2017 Apr; 8(2):. PubMed ID: 28377526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversion of the lethal phenotype of an HIV-1 integrase mutant virus by overexpression of the same integrase mutant protein.
    Priet S; Navarro JM; Quérat G; Sire J
    J Biol Chem; 2003 Jun; 278(23):20724-30. PubMed ID: 12670953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.